Europe has renowned institutions, university-supported spinout companies, public and private financial support and a great number of highly educated scholars capable of conducting modern labs, yet the European real estate market for life sciences is in its infancy due to the complexity of developing and managing research entities. 

Although an improvement was observed after the pandemics, the European life sciences market has not achieved all its objectives on a global scale, thus, it is still far from being able to cope with international competitive pressure and market forces. However, this scenario is changing little by little: European and foreign big players of real estate have been establishing alliances with local governments increasing transaction volumes across the segment, particularly outside the traditional poles. 

The result: Europe's life sciences and technology real estate sector has become an attractive opportunity for investors, in spite of the fact that not all are aware of it. Given this ever-evolving landscape, some issues need highlighting and they are at the core of this online meeting.